Shopping Cart
Remove All
Your shopping cart is currently empty
Taprenepag isopropyl (PF-04217329) is a selective EP2 agonist and prodrug of CP-544326. Following ocular administration, it induces elevated cAMP levels and reduced intraocular pressure, rendering it suitable for treating glaucoma.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $42 | - | In Stock |
| Description | Taprenepag isopropyl (PF-04217329) is a selective EP2 agonist and prodrug of CP-544326. Following ocular administration, it induces elevated cAMP levels and reduced intraocular pressure, rendering it suitable for treating glaucoma. |
| In vivo | Taprenepag isopropyl (0.75, 12, or 36 μg/day, instilled into the right eye twice daily for 28 days) demonstrated intraocular pressure-lowering effects in cynomolgus monkeys but also induced adverse reactions such as iritis, photophobia, and increased corneal thickness. These adverse reactions were reversible after discontinuation of the drug [1]. |
| Synonyms | PF-04217329, PF04217329 |
| Molecular Weight | 520.6 |
| Formula | C27H28N4O5S |
| Cas No. | 1005549-94-9 |
| Smiles | CC(C)OC(=O)COc1cccc(CN(Cc2ccc(cc2)-n2cccn2)S(=O)(=O)c2cccnc2)c1 |
| Relative Density. | 1.26 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 160 mg/mL (307.34 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 5 mg/mL (9.6 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.